mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.08 |
0.2 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.2 |
mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.23 |
0.2 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |